Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Multi-cancer blood tests promise early detection, but the evidence is thin, the risks real, and they’re no substitute for listening to your body.

When Sandia scientists Ryan Davis and Nathan Bays set out to find a better way to absorb and degrade PFAS in water sources, they kept running into the same issue: Detecting the chemicals in samples ...

An oncologist explains the situations when doctors recommend getting screened for colorectal cancer before age 45.

The challenge is timing. For years, routine screening began at 50. By 2023, rising colorectal cancer rates in young people ...

The first UK remote robotic surgery has been hailed as a “milestone” by medics. A surgeon in London operated on a patient ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Men aged 40 to 70 who get screened for disease at special event can get in fast lane to meet wrestling royalty ...

Given that one in two people will develop cancer in their lifetime, it’s in everyone’s interest to be up to speed on the ...

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...